JEREMY BRETT: Open Payments
NPI 1992391627 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,146 in 109 payments from 17 companies in 2025. Trend: 2023 $4,979 · 2024 $4,790 · 2025 $2,146
Food & beverage: $1,924Education: $222
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 11 | $477 |
| Janssen Biotech, Inc. | 7 | $368 |
| ABBVIE INC. | 6 | $235 |
| E.R. Squibb & Sons, L.L.C. | 40 | $179 |
| Arcutis Biotherapeutics, Inc. | 11 | $178 |
| PFIZER INC. | 10 | $150 |
| Organon LLC | 6 | $102 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $66 |
| Regeneron Healthcare Solutions, Inc. | 3 | $65 |
| Amgen Inc. | 3 | $56 |
Products named: Bimzelx, TREMFYA, RINVOQ, Sotyktu, Zoryve, DUPIXENT, CIBINQO, VTAMA.
Industry payments across WA — which companies pay providers there.
